1. Home
  2. Labeler Index
  3. Zydus Pharmaceuticals Usa Inc.
  4. 70710-1615
  5. NDC Package Code: 70710-1615-1 Fosaprepitant

NDC Package 70710-1615-1 Fosaprepitant

View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
70710-1615-1
Package Description:
1 VIAL in 1 CARTON / 5 mL in 1 VIAL
Product Code:
70710-1615
Proprietary Name:
Fosaprepitant
Usage Information:
Fosaprepitant for injection, in combination with other antiemetic agents, is indicated in adults for the prevention of:acute and delayed nausea and vomiting associated with initial and repeat courses of highly emetogenic cancer chemotherapy (HEC) including high-dose cisplatin.delayed nausea and vomiting associated with initial and repeat courses of moderately emetogenic cancer chemotherapy (MEC).Limitations of Use  Fosaprepitant for injection has not been studied for the treatment of established nausea and vomiting.Pediatric use information is approved for Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.'s Emend (fosaprepitant) for injection. However, due to Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.'s marketing exclusivity rights, this drug product is not labeled with that pediatric information.
11-Digit NDC Billing Format:
70710161501
Labeler Name:
Zydus Pharmaceuticals Usa Inc.
Sample Package:
No
FDA Application Number:
ANDA212957
Marketing Category:
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date:
11-01-2020
End Marketing Date:
09-30-2024
Listing Expiration Date:
09-30-2024
Exclude Flag:
D
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 70710-1615-1?

The NDC Packaged Code 70710-1615-1 is assigned to a package of 1 vial in 1 carton / 5 ml in 1 vial of Fosaprepitant, labeled by Zydus Pharmaceuticals Usa Inc.. The product's dosage form is and is administered via form.

Is NDC 70710-1615 included in the NDC Directory?

No, Fosaprepitant with product code 70710-1615 is excluded from the NDC Directory because it was discontinued by the manufacturer. The product was first marketed by Zydus Pharmaceuticals Usa Inc. on November 01, 2020 and its listing in the NDC Directory is set to expire on September 30, 2024 if the product is not updated or renewed by the manufacturer.

What is the 11-digit format for NDC 70710-1615-1?

The 11-digit format is 70710161501. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-4-170710-1615-15-4-270710-1615-01